
Blood Vessel Inflammation Drug Linked to 20 Deaths in Japan
Kissei Pharmaceutical issued a safety alert after 20 deaths among patients taking Tabneos for vasculitis. The company recommends no new prescriptions while investigations continue, and U.S. regulators propose withdrawal.











